Valeant Pharma (NYSE:VRX) Receives a Downgrade In an interesting research report revealed on Thursday morning, analysts at Mizuho’s division of equities cut shares of Valeant…
Valeant Pharma (NYSE:VRX) Receives a Downgrade Investment analysts at Mizuho’s stock research division downgraded shares of Valeant Pharma (NYSE:VRX) from a “Buy” to a “Neutral”…
Valeant Pharma (NYSE:VRX) Rating Reaffirmed New York: In a note revealed on Monday morning, RBC Capital Mkts reiterated their “Outperform” rating on Valeant Pharma (NYSE:VRX)…
Valeant Pharma (NYSE:VRX) Rating Reaffirmed In analysts note made public this morning, RBC Capital Mkts has restated their Outperform rating on Valeant Pharma (NYSE:VRX) shares….
